Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T17:36:03.864Z.
Consensus retrieved: 2026-10-06T10:22:53.812Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:36:03.864Z.
Quote observation: 2026-10-06T17:32:44.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7e5dd7cae71be814523bfc9444594aa14e5919ebae0d9bfc7936539f469f7652
Forward PE Ratio (N/A) = Dated Quote Price ($1.56) / Consensus Forward EPS ($-4.75)
FORWARD PE RATIO
N/A
Cerenome, Inc.
Market Cap
$10.74M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Cerenome, Inc. (CNSY) | $10.74M | N/A |
| Pluri Inc. (PLUR)vs › | $10.79M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.52M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.47M | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.46M | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.43M | N/A |
| BioVie Inc. (BIVI)vs › | $11.05M | N/A |
| Caring Brands, Inc. (CABR)vs › | $11.09M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.37M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $1.56, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-4.75 | $-6.41 – $-3.06 | 1 | n/m |
| 2027-12-31 | $-2.58 | $-3.47 – $-1.65 | 2 | n/m |
| 2028-12-31 | $-0.05 | $-0.07 – $-0.03 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
